BridgeMD
New treatment option for Cancer
Official title xDRIVE for Florida-based Cancer Patients
ClinicalTrials.gov ID: NCT07167381
What this study is testing
- What it's testing
- Through this study funded by the Florida Cancer Innovation Fund, First Ascent will demonstrate state-wide feasibility of providing xDRIVE Functional Precision Medicine + Artificial Intelligence platform by assessing patient clinical benefit and health economics impacts. As this is a feasibility study, results will be returned to the physician and the physician may use the data to inform the next line of treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients with recurrent/refractory cancer patients up to age 18 (willing to sign assent if ages 7 - 17 years)
- -OR- Patients with recurrent/refractory cancer ≥18 years of age.
- Patients who have received at least one prior line of standard of care therapy.
- Patients able to provide treatment and outcome information from previous line(s) of therapy.
- Patients with sufficient health status to undergo cancer therapy, e.g., Eastern Cooperative Group (ECOG) performance status of 0, 1, or 2 for adult...
You likely can't join if
- Patients who do not have malignant tissue available and accessible, patients where the amount of excised malignant tissue is insufficient material...
- Patients with insufficient health indicators to undergo therapeutic intervention.
See the full eligibility criteria
- Patients with recurrent/refractory cancer patients up to age 18 (willing to sign assent if ages 7 - 17 years)
- -OR- Patients with recurrent/refractory cancer ≥18 years of age.
- Patients who have received at least one prior line of standard of care therapy.
- Patients able to provide treatment and outcome information from previous line(s) of therapy.
- Patients with sufficient health status to undergo cancer therapy, e.g., Eastern Cooperative Group (ECOG) performance status of 0, 1, or 2 for adult patients.
- Patients who are scheduled for or have recently undergone a tumor biopsy, excision, or resection.
- Patients willing to have a blood draw or buccal swab performed for matched normal material for comparison during tumor DNA profiling.
- Patients who do not have malignant tissue available and accessible, patients where the amount of excised malignant tissue is insufficient material for ex vivo drug testing and/or genetic profiling, defined as \<0.3g for...
- Patients with insufficient health indicators to undergo therapeutic intervention.
The study team makes the final eligibility decision.
Where it's taking place
- Miami, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Miami, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.